Literature DB >> 8635859

Novel HPV types present in oral papillomatous lesions from patients with HIV infection.

C Völter1, Y He, H Delius, A Roy-Burman, J S Greenspan, D Greenspan, E M de Villiers.   

Abstract

Patients infected with the human immunodeficiency virus (HIV) often develop multiple papillomatous lesions of the oral cavity. In the present study, a total of 67 biopsies from benign oral lesions were analyzed for the presence of human papillomavirus (HPV) DNA using Southern-blot hybridization in combination with a polymerase chain reaction designed to detect all known HPV types, as well as unidentified types. These samples, collected at random from a high-risk population, were subsequently divided into 57 biopsies originating from patients with confirmed HIV infection and 10 biopsies from patients with unknown HIV status. Each sample was amplified with 7 different combinations of degenerate primers. All amplified products were sequenced. HPV DNA sequences were detected in 67% (45/67) of the samples. HPV 7 (19%) and HPV 32 (28%) were the predominant HPV types. HPV 32 was present in 2/4 fibromas tested. Two new HPV types, HPV 72 and HPV 73, were identified in oral warts with atypia. The complete genomes of these viruses were cloned and sequenced. Other HPV types detected were HPV 2a, HPV 6b, HPV 13, HPV 16, HPV 18, HPV 55, HPV 59 and HPV 69.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8635859     DOI: 10.1002/(SICI)1097-0215(19960516)66:4<453::AID-IJC7>3.0.CO;2-V

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

Review 1.  Oral Sex and HPV: Population Based Indications.

Authors:  Anupam Mishra; Veerendra Verma
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-02-29

2.  Oral Human Papillomavirus Infection and Oral Lesions in HIV-Positive and HIV-Negative Dental Patients.

Authors:  Katia Muller; Julie Kazimiroff; Mahnaz Fatahzadeh; Richard V Smith; Mauricio Wiltz; Jacqueline Polanco; Robert M Grossberg; Thomas J Belbin; Howard D Strickler; Robert D Burk; Nicolas F Schlecht
Journal:  J Infect Dis       Date:  2015-02-13       Impact factor: 5.226

3.  Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87.

Authors:  S Menzo; A Monachetti; C Trozzi; A Ciavattini; G Carloni; P E Varaldo; M Clementi
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women.

Authors:  Carole Fakhry; Gypsyamber D'souza; Elizabeth Sugar; Kathleen Weber; Eleni Goshu; Howard Minkoff; Rodney Wright; Eric Seaberg; Maura Gillison
Journal:  J Clin Microbiol       Date:  2006-10-04       Impact factor: 5.948

Review 5.  Oral HPV complications in HIV-infected patients.

Authors:  Jennifer E Cameron; Michael E Hagensee
Journal:  Curr HIV/AIDS Rep       Date:  2008-08       Impact factor: 5.071

6.  Quantitative Proteomic Analysis of Formalin Fixed Paraffin Embedded Oral HPV Lesions from HIV Patients.

Authors:  Mohit Raja Jain; Tong Liu; Jun Hu; Marlene Darfler; Valerie Fitzhugh; Joseph Rinaggio; Hong Li
Journal:  Open Proteomics J       Date:  2008

Review 7.  Human papillomavirus infections and oral tumors.

Authors:  Stina Syrjänen
Journal:  Med Microbiol Immunol       Date:  2003-01-18       Impact factor: 3.402

Review 8.  Oral manifestations in the era of HAART.

Authors:  Gail Cherry-Peppers; Christine O Daniels; Valli Meeks; Charles F Sanders; David Reznik
Journal:  J Natl Med Assoc       Date:  2003-02       Impact factor: 1.798

9.  Epithelial maturation and molecular biology of oral HPV.

Authors:  Liviu Feller; Razia Ag Khammissa; Neil H Wood; Johan Lemmer
Journal:  Infect Agent Cancer       Date:  2009-11-25       Impact factor: 2.965

10.  Development and validation of a HPV-32 specific PCR assay.

Authors:  Nicholas R Herrel; Nadia L Johnson; Jennifer E Cameron; Janet Leigh; Michael E Hagensee
Journal:  Virol J       Date:  2009-06-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.